» Articles » PMID: 36238382

Risk Factors for Cancer-specific Survival in Elderly Gastric Cancer Patients After Curative Gastrectomy

Overview
Journal Nutr Res Pract
Date 2022 Oct 14
PMID 36238382
Authors
Affiliations
Soon will be listed here.
Abstract

Background/objectives: This study aimed to investigate cancer-specific survival (CSS) and associated risk factors in elderly gastric cancer (EGC) patients.

Subjects/methods: EGC patients (≥ 70 yrs) who underwent curative gastrectomy between January 2013 and December 2017 at our hospital were included. Clinicopathologic characteristics and survival data were collected. Receiver operating characteristic (ROC) analysis was used to extract the best cutoff point for body mass index (BMI). A Cox proportional hazards model was used to determine the risk factors for CSS.

Results: In total, 290 EGC patients were included, with a median age of 74.7 yrs. The median follow-up time was 31 (1-77) mon. The postoperative 1-yr, 3-yr and 5-yr CSS rates were 93.7%, 75.9% and 65.1%, respectively. Univariate analysis revealed risk factors for CSS, including age (hazard ratio [HR] = 1.08; 95% confidence interval [CI], 1.01-1.15), intensive care unit (ICU) admission (HR = 1.73; 95% CI, 1.08-2.79), nutritional risk screening (NRS 2002) score ≥ 5 (HR = 2.33; 95% CI, 1.49-3.75), and preoperative prognostic nutrition index score < 45 (HR = 2.06; 95% CI, 1.27-3.33). The ROC curve showed that the best BMI cutoff value was 20.6 kg/m. Multivariate analysis indicated that a BMI ≤ 20.6 kg/m (HR = 2.30; 95% CI, 1.36-3.87), ICU admission (HR = 1.97; 95% CI, 1.17-3.30) and TNM stage (stage II: HR = 5.56; 95% CI, 1.59-19.43; stage III: HR = 16.20; 95% CI, 4.99-52.59) were significantly associated with CSS.

Conclusions: Low BMI (≤ 20.6 kg/m), ICU admission and advanced pathological TNM stages (II and III) are independent risk factors for CSS in EGC patients after curative gastrectomy. Nutrition support, better perioperative management and early diagnosis would be helpful for better survival.

Citing Articles

Controlling Nutritional Status (CONUT) Score as Prognostic Indicator in Stage IV Gastric Cancer with Chronic Intestinal Failure.

Matysiak K, Hojdis A, Szewczuk M Nutrients. 2024; 16(23).

PMID: 39683445 PMC: 11643072. DOI: 10.3390/nu16234052.

References
1.
Cederholm T, Bosaeus I, Barazzoni R, Bauer J, Van Gossum A, Klek S . Diagnostic criteria for malnutrition - An ESPEN Consensus Statement. Clin Nutr. 2015; 34(3):335-40. DOI: 10.1016/j.clnu.2015.03.001. View

2.
Lee L, Cheung W, Atkinson E, Krzyzanowska M . Impact of comorbidity on chemotherapy use and outcomes in solid tumors: a systematic review. J Clin Oncol. 2010; 29(1):106-17. DOI: 10.1200/JCO.2010.31.3049. View

3.
Mizuno A, Kanda M, Kobayashi D, Tanaka C, Iwata N, Yamada S . Adverse Effects of Intraoperative Blood Loss on Long-Term Outcomes after Curative Gastrectomy of Patients with Stage II/III Gastric Cancer. Dig Surg. 2016; 33(2):121-8. DOI: 10.1159/000443219. View

4.
Chen W, Zheng R, Zhang S, Zeng H, Zou X, He J . [Analysis of cancer incidence and mortality in elderly population in China, 2013]. Zhonghua Zhong Liu Za Zhi. 2017; 39(1):60-66. DOI: 10.3760/cma.j.issn.0253-3766.2017.01.012. View

5.
Edwards B, Noone A, Mariotto A, Simard E, Boscoe F, Henley S . Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2013; 120(9):1290-314. PMC: 3999205. DOI: 10.1002/cncr.28509. View